Low-dose versus high-dose heparinization during arteriovenous carbon dioxide removal

Perfusion

Volumn 16, Issue 6, 2001, Pages 460-468

  Murphy, J A ^a   Savage, C M ^b   Alpard, S K ^a   Deyo, D J ^a   Jayroe, J B ^a   Zwischenberger, J B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; FIBRIN DEGRADATION PRODUCT; HEPARIN; BIOMATERIAL; FIBRINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOVENOUS SHUNT; ARTERY; ARTICLE; BLEEDING; BLOOD CARBON DIOXIDE TENSION; BLOOD CLOTTING TIME; BLOOD FLOW; BURN; CANNULATION; CAROTID ARTERY; CONTROLLED STUDY; DISEASE SEVERITY; HEART OUTPUT; HEMATOCRIT; HEPARINIZATION; JUGULAR VEIN; LD 50; LUNG BURN; LUNG INJURY; NONHUMAN; OXYGENATOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RESPIRATORY DISTRESS; THROMBOCYTE COUNT; THROMBOGENESIS; THROMBOSIS; ACUTE DISEASE; ANIMAL; BLOOD; BLOOD FLOW VELOCITY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; EXTRACORPOREAL OXYGENATION; FEMALE; METABOLISM; METHODOLOGY; RESPIRATORY FAILURE; SHEEP; STANDARD; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMAL; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD FLOW VELOCITY; CARBON DIOXIDE; COATED MATERIALS, BIOCOMPATIBLE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FIBRINOGEN; HEPARIN; OXYGENATORS, MEMBRANE; PLATELET COUNT; RESPIRATORY INSUFFICIENCY; SHEEP; TREATMENT OUTCOME; WHOLE BLOOD COAGULATION TIME;

EID: 0035177120     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910101600605     Document Type: Article

References (27)

1. Extracorporeal gas exchange
2. Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization
3. 2 removal: Simplifying extracorporeal support for respiratory failure
4. Prolonged hemodynamic stability during arteriovenous carbon dioxide removal for severe respiratory failure
5. Percutaneous arteriovenous carbon dioxide removal improves survival in respiratory distress syndrome: A prospective randomized outcomes study in sheep
6. 2 removal for severe respiratory failure
7. Surface interface
8. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support
9. New clinically relevant sheep model of severe respiratory failure secondary to combined smoke inhalation/cutaneous flame burn injury
10. Burns
11. Reduced ventilator pressure and improved P/F ratio during percutaneous arteriovenous carbon dioxide removal for severe respiratory failure
12. Platelet function and coagulation parameters in sheep during experimental vascular surgery
13. Blood coagulation studies during six day heparinless venoarterial bypass in sheep
14. Haematology of the sheep and goat: (a) the sheep
15. Anticoagulation for cardiopulmonary bypass
16. Anticoagulation practices during neonatal extracorporeal membrane oxygenation: Survey results
17. Principles of heparin-coating techniques
18. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue
19. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits
20. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems
21. Experimental studies on three types of heparin-coated cardiopulmonary bypass circuits
22. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation
23. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: Heparin-bonded versus nonbonded oxygenators
24. Heparin-bonded circuits: Clinical outcomes and costs
25. Heparincoated circuits for high-risk patients: A multicenter, prospective, randomized trial
26. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation